Top Markets
Coin of the day
MaaT Pharma S.A. MaaT Pharma S.A.

MaaT Pharma S.A.

MAAT
Rang în acțiuni #23616
MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on... MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on the discovery and advancement of microbiome-based biotherapies, primarily for the treatment of solid cancer tumors. Its development pipeline features MaaT013, which has successfully completed Phase 2 clinical trials for acute graft-versus-host disease (aGVHD) and is also undergoing preclinical evaluation for melanoma. Another therapeutic candidate, MaaT033, is currently in Phase 1b clinical trials, aiming to improve survival outcomes for patients with acute myeloid leukemia (AML) or other liquid malignancies following allogeneic hematopoietic stem cell transplantation. Furthermore, MaaT03X is being developed specifically for solid tumor applications. The company was founded in 2014 and maintains its headquarters in Lyon, France.
Preț acțiune
$3.78
Ultima sincronizare: 2026-08-21
Capitalizare de piață
$71.20M
Schimbare (1 zi)
2.24%
Schimbare (1 an)
-43.37%
Țară
FR
Tranzacționează MaaT Pharma S.A. (MAAT)

Categorie

Istoricul randamentului dividendelor pentru MaaT Pharma S.A. (MAAT)
Randamentul dividendelor (TTM) pentru MaaT Pharma S.A. (simbol acțiune: MAAT) la data de 2026 este: 0
Randamentul mediu al dividendelor în ultimii 5 ani: 0.00%
Istoric al randamentului dividendelor pentru MaaT Pharma S.A. (MAAT) între 2026 și 2026
Randamentul dividendelor la sfârșitul fiecărui an (TTM)
An Randamentul dividendelor Schimbă
Nu sunt suficiente date pentru perioada selectată.
Randamentele dividendelor (TTM) pentru companii similare sau concurente
Companie Randamentul dividendelor Țara
0.00%
US
0.00%
NL
0.00%
US
3.12%
AU
0.00%
CH